新生大鼠小肠上皮细胞分离培养研究

本实验比较了4种分离大鼠IEC的方法,结果显示联合应用粗胶原酶和中性蛋白酶分离效果最好,细胞贴壁生长能力强。胶原涂膜改善玻璃培养瓶或盖玻片表面的性状有利于细胞贴壁生长。细胞的增殖依赖于培养液的质量、成分及细胞间的相互作用。培养细胞一般1～2天贴壁,7～8天明显增殖,10～14天汇合成片。培养细胞细胞角质蛋白、碱性磷酸酶染色阳性,光镜和电镜检查均显示为IEC。本文所建立的新生大鼠IEC体外培养方法为研究IEC生理和病理提供了一个十分有用的实验模型。     

Rats' memory for event duration: differential effects of delaying the discriminative choice cue as opposed to the opportunity to execute the choice response

Rats were trained to discriminate short or long durations of houselight illumination using a choice procedure. During the test phase of each trial, the left and right levers were presented with an auditory cue above one of them on (cued lever) while the other was off (uncued lever). The auditory cue was presented immediately after sample offset and the levers were inserted after the auditory cue had been presented for 2 s. For half of the rats, the correct response following the short sample was to press the cued lever, while following the long sample, it was to press the uncued lever. This was reversed for the remaining rats. Following acquisition of the discrimination, two different types of delay tests were administered. In the first set, the delay between offset of the sample and onset of the auditory cue was manipulated (Cue Delay Test). In the second set, the delay between onset of the auditory cue and entry of the levers into the chamber was manipulated (Response Delay Test). Cue Delay testing resulted in a choose-long bias at the longer delays. Response Delay testing did not result in a systematic response bias and there was little forgetting over the delay interval. These data suggest that the rats did not stop the internal clock when the nominal sample was offset, but allowed it to keep running until the auditory cue was presented. The data from the Response Delay Test indicate that either a response decision was made based on the clock reading as soon as the auditory cue was presented, or the clock reading itself was retained over the delay with no subjective shortening and little forgetting.     

大鼠实验性脾虚证胰腺组织化学研究

用成年雄性Ｗｉｓｔａｒ大鼠３０只,分为（１）正常对照组,喂饲自来水。（２）脾虚组,用苦降破气中药和饮食失节法致成脾虚模型。（３）自然恢复组,动物致虚后,喂饲自来水。（４）中药治疗组。取四组动物胰腺进行ＲＮＡ,琥珀酸脱氢酶（ＳＤＨ）,乳酸脱氢酶（ＬＤＨ）,三磷酸腺苷酶（ＡＴＰａｓｅ）,葡萄糖－６－磷酸酶（Ｇ－６－Ｐａｓｅ）和硫胺素焦磷酸酶（ＴＰＰａｓｅ）组织化学反应和观察,并对ＳＤＨ,ＬＤＨ,ＲＮＡ进行了显微分光光度计定量测定。本研究结果表明,脾虚组胰腺泡细胞的ＲＮＡ,ＳＤＨ,ＡＴＰａｓｅ,Ｇ－６－Ｐａｓｅ,ＴＰＰａｓｅ含量和活性都低于对照组,而ＬＤＨ活性高于对照组。治疗组与自然恢复组相比,治疗组胰腺泡细胞以上指标接近对照组。定量测定与定性的结果一致。本研究表明,脾虚证时胰腺泡细胞上述几种酶活性和ＲＮＡ明显下降,可能在脾虚证发病中起主要作用,中药治疗有显著改善     

铝对大白鼠海马所致损害的实验研究

为探讨铝对海马的损害,用３０只健康大白鼠,体重２００～３００克,分为Ａ组（正常对照）１０只,Ｂ组（低铝组饲料中加５００ｍｇ／ｋｇＡｌＣｌ３）１０只,Ｃ组（高铝组饲料中加２５００ｍｇ／ｋｇ／ＡｌＣｌ３）１０只。分别饲养１２个月后,分组断头取脑海马,按组织化学及酶组织化学常规做“铝定性”反应,琥珀酸脱氢酶（ＳＤＨ）、乳酸脱氢酶（ＬＤＨ）、硫胺素焦磷酸酶（ＴＰＰａｓｅ）、镁激活三磷酸腺苷酶（Ｍｇ２＋－ＡＴＰａｓｅ）、胆碱酯酶（ＣｈＥ）测定。按电镜常规做超微结构的观察。结果提示：Ｃ组,海马ＳＤＨ、Ｍｇ２＋－ＡＴＰａｓｅ、ＣｈＥ活性明显减弱（由强阳性（）下降为阳性（＋）,铝反应增强（在海马的神经细胞内强阳性（）;同时海马神经元内线粒体嵴断裂、肿胀、空泡样变,神经纤维髓鞘变性（如不规则卷曲、松散）。说明铝对海马的功能与结构均有损害     

大鼠脊髓心房利钠肽的基因表达

用地高辛配基标记的ＡＮＰｃＤＮＡ作为探针,与大鼠脊髓腰段切片原位杂交,观察到杂交反应阳性神经元主要分布于前角（ⅨⅧ层）,少数中间带（Ⅶ层）和后角基部（Ⅶ层）。脊髓中央管室管膜上皮呈弱阳性反应。结果提示脊髓前角神经元和中央管室管膜上皮存在着ＡＮＰｍＲＮＡ,能内源性合成ＡＮＰ。     

Phosphatidylinositol hydrolysis and phosphatidylinositol 4′,5′-diphosphate hydrolysis are separable responses during secretagogue action in the rat pancreas

Rat pancreatic fragments and acinar preparations were incubated in vitro to characterize further the changes in phosphoinositide metabolism that occur during secretagogue action. Two distinct responses were discernible. The first response, most notably involving a decrease in phosphatidylinositol content, was (a) observed at lower carbachol concentrations in dose-response studies, (b) inhibited by incubation in Ca²⁺-free media containing 1 mM EGTA, (c) associated with increases in inositol monophosphate production, and (d) provoked by all tissue secretagogues (carbachol, cholecystokinin, secretin, insulin, dibutyryl cAMP and the ionophore A23187), regardless of whether their mechanism of action primarily involved Ca²⁺ mobilization or cAMP generation. This decrease in phosphatidylinositol content was at least partly due to phospholipase C (and/or D) activation, as evidenced by the increase in inositol monophosphate. The second response, most notably involving markedly increased incorporation of ³²PO₄ into phosphatidic acid and phosphatidylinositol, was (a) observed at higher carbachol concentrations, (b) not influenced by incubation in Ca²⁺-free media containing 1 mM EGTA, and (c) associated with increases in inositol triphosphate production. This ³²PO₄ turnover response was probably largely the result of phospholipase C-mediated hydrolysis of phosphatidylinositol 4′,5′-diphosphate, which, as shown previously, also occurs at higher carbachol concentrations and is insensitive to comparable EGTA-induced Ca²⁺ deficiency. This phosphatidylinositol 4′,5′-diphosphate hydrolysis response was only observed in the action of agents (carbachol and cholecystokinin) which mobilize Ca²⁺ via activation of cell surface receptors. The present results indicate that phosphatidylinositol and phosphatidylinositol 4′,5′-diphosphate hydrolysis are truly separable responses to secretagogues acting in the rat pancreas. Furthermore, phosphatidylinositol 4′,5′-diphosphate, rather than phosphatidylinositol hydrolysis is more likely to be associated with receptor activation and Ca²⁺ mobilization.     

Stimulation of fibrinogen synthesis in cultured rat hepatocytes by fibrinogen fragment E

Because of the inherent difficulties of experimentation in intact animals, we used primary monolayer cultures of non-proliferating adult rat hepatocytes to study the effects of fibrinogen degradation products on fibrinogen biosynthesis. The freshly isolated hepatocytes obtained by collagenase perfusion of the liver in situ were cultured in a chemically defined serum-free medium. The rate of fibrinogen synthesis in control cultures was $\text{40–50}\text{pmol}\text{2.5·10}{}^6$ cells per 24 h. Additions of 20, 60 or 100 μg of homologous stage I fibrinogen degradation products had no effect on fibrinogen synthesis. In contrast, addition of the same amounts of homologous or heterologous (human) stage III fibrinogen degradation products resulted in a concentration-dependent increase in fibrinogen biosynthesis without affecting the rate of synthesis of albumin. When purified stage III fibrinogen degradation products D and E (human) were tested in 10, 30 or 50 μg/3 ml medium only fragment E showed a significant increase in fibrinogen biosynthesis (1.9-, 2.8- and 5.6-fold, respectively, over the control cultures). The presence of excess fibrinogen had no effect. These results suggest that fibrinogen fragment E may be a specific stimulator of fibrinogen biosynthesis which may play an important role in maintaining normal levels of plasma fibrinogen.     

Sarcolemmal glucose transport in Ca2+-tolerant myocytes from adult rat heart. Calcium dependence of insulin action

Cardiac myocytes were isolated from adult rat ventricles by a method which preserves their functional integrity, including long survival in physiological concentrations of Ca²⁺. Sarcolemmal glucose transport was assessed by measuring linear initial uptake rates of the nonmetabolized glucose analog3-O-methyl-d-glucose. Transport was saturable and showed competition byd-glucose and other features of chemical and stereo-selectivity. Transport was stimulated by insulin in a dose-dependent manner, resulting in an almost 5-fold increase inV_max, with little change inK_m. Stimulation of 3-methylglucose transport by insulin was largely Ca²⁺ -dependent. Omission of Ca²⁺ from the incubation medium caused a minor rise in basal 3-methylglucose uptake but the insulin-stimulated rise inV_max was only 30%. The Ca²⁺ antagonist D600 also antagonized stimulation of hexose transport by insulin. In all the above respects, 3-methylglucose transport in myocytes is identical to that in intact heart muscle. In addition, the decrease in insulin response by Ca²⁺ emission was partially reversed by subsequent return to a Ca²⁺ -containing medium. ATP levels remained stable in the absence of Ca²⁺, showing that the Ca²⁺ dependence did not reflect nonspecific cell damage.     

Influence of treatment of diabetic rats with combinations of pycnogenol, β‐carotene,and α‐lipoic acid on parameters of oxidative stress

Treatment with antioxidants may act more effectively to alter markers of free radical damage in combinations than singly. This study has determined whether treatment with combinations of pycnogenol, β‐carotene, and α‐lipoic acid was more effective at reducing oxidative stress in diabetic rats than treatment with these antioxidants alone. It is not feasible, based on this study, to assume that there are interactive effects that make combinations of these antioxidants more effective than any one alone to combat oxidative stress. Female Sprague‐Dawley rats, normal and streptozotocin‐induced diabetic, were treated (10 mg/kg/day ip for 14 days) with pycnogenol, β‐carotene, pycnogenol + β‐carotene, or pycnogenol + β‐carotene + α‐lipoic acid; controls were untreated. Concentrations of thiobarbituric acid reactive substances, glutathione and glutathione disulfide, and activities of glutathione reductase, glutathione peroxidase, superoxide dismutase, and catalase were measured in liver, kidney, and heart. Four types of effects were observed: (1) treatment with β‐carotene alone either reversed (cardiac glutathione disulfide) or elevated (cardiac glutathione, hepatic glutathione peroxidase activity) levels seen in diabetic animals; (2) β‐carotene alone produced no effect, but pycnogenol both alone and in combinations elevated (renal glutathione peroxidase and glutathione reductase activities, hepatic glutathione reductase activity and glutathione disulfide) or depressed (cardiac glutathione disulfide) levels seen in untreated diabetic animals; (3) all treatments with antioxidants, either alone or in combination, either normalized (lipid peroxidation in all tissues), elevated (hepatic GSH, cardiac glutathione peroxidase activity), or had no effect on (activities of hepatic catalase and superoxide dismutase in all tissues) levels seen in diabetic animals; (4) in only one case (cardiac glutathione reductase activity) levels in diabetic animals treated with combinations of antioxidants were normal, but elevated in animals treated with either antioxidant alone. Antioxidant effects seem to be dependent on the nature of the antioxidant used and not on combination effects. © 2005 Wiley Periodicals, Inc. J Biochem Mol Toxicol 18:345–352, 2004; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/jbt.20046     

Mrp1 Multidrug Resistance-Associated Protein and P-Glycoprotein Expression in Rat Brain Microvessel Endothelial Cells

Abstract: Two membrane glycoproteins acting as energy-dependent efflux pumps, mdr -encoded P-glycoprotein (P-gp) and the more recently described multidrug resistance-associated protein (MRP), are known to confer cellular resistance to many cytotoxic hydrophobic drugs. In the brain, P-gp has been shown to be expressed specifically in the capillary endothelial cells forming the blood-brain barrier, but localization of MRP has not been well characterized yet. Using RT-PCR and immunoblot analysis, we have compared the expression of P-gp and Mrp1 in homogenates, isolated capillaries, primary cultured endothelial cells, and RBE4 immortalized endothelial cells from rat brain. Whereas the mdr1a P-gp-encoding mRNA was specifically detected in brain microvessels and mdr1b mRNA in brain parenchyma, mrp1 mRNA was present both in microvessels and in parenchyma. However, Mrp1 was weakly expressed in microvessels. Mrp1 expression was higher in brain parenchyma, as well as in primary cultured brain endothelial cells and in immortalized RBE4 cells. This Mrp1 overexpression in cultured brain endothelial cells was less pronounced when the cells were cocultured with astrocytes. A low Mrp activity could be demonstrated in the endothelial cell primary monocultures, because the intracellular [³H]vincristine accumulation was increased by several MRP modulators. No Mrp activity was found in the cocultures or in the RBE4 cells. We suggest that in rat brain, Mrp1, unlike P-gp, is not predominantly expressed in the blood-brain barrier endothelial cells and that Mrp1 and the mdr1b P-gp isoform may be present in other cerebral cells.